chr1-201087846-C-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6_Very_StrongBP7
The NM_000069.3(CACNA1S):c.984G>T(p.Leu328Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000092   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000075   (  0   hom.  ) 
Consequence
 CACNA1S
NM_000069.3 synonymous
NM_000069.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.887  
Publications
0 publications found 
Genes affected
 CACNA1S  (HGNC:1397):  (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008] 
CACNA1S Gene-Disease associations (from GenCC):
- congenital myopathy 18Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hypokalemic periodic paralysis, type 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- malignant hyperthermia, susceptibility to, 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital myopathyInheritance: SD, AR, AD Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
- hypokalemic periodic paralysisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.18). 
BP6
Variant 1-201087846-C-A is Benign according to our data. Variant chr1-201087846-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 254856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=0.887 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000921  AC: 14AN: 152062Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
14
AN: 
152062
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000279  AC: 7AN: 251326 AF XY:  0.0000294   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
7
AN: 
251326
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000753  AC: 11AN: 1461124Hom.:  0  Cov.: 31 AF XY:  0.00000825  AC XY: 6AN XY: 726942 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
11
AN: 
1461124
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
6
AN XY: 
726942
show subpopulations 
African (AFR) 
 AF: 
AC: 
9
AN: 
33472
American (AMR) 
 AF: 
AC: 
0
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86234
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53412
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111336
Other (OTH) 
 AF: 
AC: 
2
AN: 
60358
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.448 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000921  AC: 14AN: 152062Hom.:  0  Cov.: 32 AF XY:  0.0000673  AC XY: 5AN XY: 74252 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
14
AN: 
152062
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
5
AN XY: 
74252
show subpopulations 
African (AFR) 
 AF: 
AC: 
13
AN: 
41412
American (AMR) 
 AF: 
AC: 
0
AN: 
15254
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10588
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68016
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.464 
Heterozygous variant carriers
 0 
 1 
 2 
 4 
 5 
 6 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Malignant hyperthermia, susceptibility to, 5;C2749982:Thyrotoxic periodic paralysis, susceptibility to, 1;C3714580:Hypokalemic periodic paralysis, type 1    Benign:1 
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypokalemic periodic paralysis, type 1    Benign:1 
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital myopathy 18    Benign:1 
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Thyrotoxic periodic paralysis, susceptibility to, 1    Benign:1 
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1    Benign:1 
Feb 18, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Malignant hyperthermia, susceptibility to, 5    Benign:1 
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.